Company Filing History:
Years Active: 2011-2012
Title: **Innovative Contributions of Sandy D Der in Lung Cancer Research**
Introduction
Sandy D Der is a prominent inventor based in Toronto, Canada. He has made significant contributions to the field of oncology, particularly in the prognostication and classification of lung cancer patients. With two notable patents to his name, Der is recognized for his innovative approaches to improving patient outcomes through genetic insights.
Latest Patents
Sandy D Der holds two pivotal patents that focus on non-small cell lung cancer. His latest patent, titled "Prognostic and Predictive Gene Signature for Non-Small Cell Lung Cancer and Adjuvant Chemotherapy," outlines methods for classifying lung cancer patients into distinct survival groups. This application aims to determine the benefits of adjuvant chemotherapy using a multigene signature. In addition, the patent includes kits and computer products designed to facilitate these methods. Another significant invention is "Materials and Methods for Prognosing Lung Cancer Survival," which provides similar classifications and includes kits for practical applications in clinical settings.
Career Highlights
Sandy D Der is affiliated with the University Health Network, where his research focuses on developing innovative solutions to enhance cancer treatment and prognosis. His work is instrumental in advancing the understanding of lung cancer, particularly its genetic implications for patient care.
Collaborations
Throughout his career, Der has collaborated with notable professionals in the field, including Frances A Shepherd, a distinguished researcher and advocate for cancer patients, and Igor Jurisica, who contributes valuable insights into computational biology and cancer research. These collaborations have bolstered his patents and enriched the research environment.
Conclusion
Sandy D Der’s innovative patents are vital contributions to lung cancer research, reflecting his commitment to improving patient outcomes. His collaborative efforts and dedication to scientific advancement continue to influence the field, providing hope for many individuals affected by this challenging disease.